In the decade since the last Lancet Seminar on lung cancer there have been advances in
many aspects of the classification, diagnosis, and treatment of non-small-cell lung cancer (…

… A pooled analysis showed that a positive family history of lung cancer predisposes
individuals to develop lung cancer 53 . Lung adenocarcinoma is more likely to have a genetic …

… The primary risk factor for lung cancer is smoking, which accounts for more than 85% of all
lung cancer-related deaths. The risk for lung cancer increases with the number of cigarettes …

… Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been
achieved over the past two decades, increasing our understanding of the disease biology …

… Lung cancer is the leading cause of cancer death in the … in women) of lung and bronchial
cancer will be diagnosed in … whereas small cell lung carcinoma is negative in 25% of cases. …

… Among patients with non–small-cell lung cancer (NSCLC), data on intratumor heterogeneity
and cancer genome evolution have been limited to small retrospective cohorts. We wanted …

… Non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States.
After the initial diagnosis, accurate staging of non-small cell lung cancer using computed …

… lung cancers—KRAS—… cancers without targetable mutations, those with targetable mutations
who have progressed through targeted therapy, and those with squamous cell lung cancers…

… Therefore, it is important to perform molecular testing on tumor tissue from patients with
advanced non–small cell lung cancer (NSCLC) to determine whether they have genetic …

… The International Association for the Study of Lung Cancer Staging Project: prognostic
factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac …